Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Siavash Gholami"'
Autor:
Seyed Mohsen Dehghani, Mohammad Reza Bordbar, Rezvan Salimi, Iraj Shahramian, Hadi Mirzae, Siavash Gholami, Fatemeh Sharafi, Ali Bazi, Maryam Ataollahi, Fatemeh Fazeli, Samaneh Hamzeloo
Publikováno v:
International Journal of Basic Science in Medicine, Vol 5, Iss 4, Pp 131-135 (2020)
Introduction: Almost all causes of chronic liver damage can culminate in liver fibrosis and ultimately cirrhosis. Studies have suggested a relationship between mean platelet volume (MPV) and liver fibrosis; however, this needs confirmation by further
Externí odkaz:
https://doaj.org/article/760b18f49e4c47e78ecb45c6b2fff79d
Autor:
Hamed Nikoupour, Kourosh Kazemi, Peyman Arasteh, Saba Ghazimoghadam, Hesameddin Eghlimi, Naghi Dara, Siavash Gholami, Saman Nikeghbalian
Publikováno v:
BMC Surgery, Vol 20, Iss 1, Pp 1-3 (2020)
Abstract Background Immunosuppressed patients, including individuals with organ transplantation, have been among susceptible groups with regard to COVID-19, on the other hand pediatric patients more commonly undergo a mild clinical course after acqui
Externí odkaz:
https://doaj.org/article/353134733a714a42bc2dcd797b4d1837
Publikováno v:
BMC Surgery, Vol 20, Iss 1, Pp 1-3 (2020)
Abstract Background To this date little information exists on the effects, clinical course and outcome of the COVID-19 among patients undergoing transplantation. Case presentation A 35 year old male referred with loss of sense of smell and taste afte
Externí odkaz:
https://doaj.org/article/b5ee51d2f2114f4bb563008e74bec2e5
Autor:
Ahad, Eshraghian, Hamed, Nikoupour, Masood, Dehghani, Siavash, Gholami, Alireza, Shamsaeefar, Kourosh, Kazemi, Ahmad Khalid, Sanaei, Alireza, Taghavi, Seyed Ali, Malek-Hosseini, Saman, Nikeghbalian
Publikováno v:
Experimental and Clinical Transplantation. 20:925-929
Coronavirus disease 2019 has resulted in significant morbidities and mortalities in nearly all parts ofthe world. There remain major concerns about management, timing, and safety of liver transplant in patients who have recovered from COVID-19. We ai
Autor:
Seyed Ali Malekhosseini, Younes Ghasemi, Javad Rousta, Roghayyeh Aghaei, Sedigheh Kianpour, Manica Negahdaripour, Reza Heidari, Alireza Shamsaeefar, Siavash Gholami, Saman Nikeghbalian
Publikováno v:
Archives of Iranian Medicine. 25:617-623
Background: Organ preservation solutions are not easily accessible in Iran, similar to many resource-limited countries. We aimed to evaluate the efficacy of a locally-produced HTK solution among adult liver transplantation candidates in a pilot clini
Autor:
Fateme Parooie, А. Aminisefat, Siavash Gholami, Kurosh Kazemi, Iraj Shahramian, Maryam Ataollahi, Morteza Salarzaei, F. Salimi, S. М. Dehghani
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 23, Iss 3, Pp 50-60 (2021)
Back ground. Liver transplantation is an effective treatment for acute or chronic liver failure and metabolic liver disease, which is associated with good quality of life in over 80 percent of recipients. We aimed to evaluate outcome of duct-to-duct
Autor:
Fatemeh Sharafi, Hadi Mirzae, Seyed Mohsen Dehghani, Fatemeh Fazeli, Maryam Ataollahi, Siavash Gholami, Rezvan Salimi, Mohammadreza Bordbar, Iraj Shahramian, Ali Bazi, Samaneh Hamzeloo
Publikováno v:
International Journal of Basic Science in Medicine, Vol 5, Iss 4, Pp 131-135 (2020)
Introduction: Almost all causes of chronic liver damage can culminate in liver fibrosis and ultimately cirrhosis. Studies have suggested a relationship between mean platelet volume (MPV) and liver fibrosis; however, this needs confirmation by further
Autor:
Mojtaba Shafiekhani, Hamed Nikoupour, Mahtabsadat Mirjalili, Jamshid Roozbeh, Siavash Gholami
Publikováno v:
Transplantation. 106:S747-S748
Autor:
Seyyed Mohsen Dehghani, Siavash Gholami, Ali Bahador, Seyyed Ali Malek Hosseini, Razieh Rasekh, Mohammad Hussein Al Sayyed, Bahareh Khosravi, Masood Dehghani, Saman Nikeghbalian, Alireza Shamsaeefar
Publikováno v:
Experimental and Clinical Transplantation. 18:65-70
OBJECTIVES Liver replacement continues to be the only definitive mode of therapy for children with end-stage liver disease. However, it remains challenging because of the rare donor organs, complex surgical demands, and the necessity to prevent long-
Autor:
Ramin Yaghoubi, Behzad Dehghani, Farzaneh Ghassabi, Javad Moayedi, Mehrdad Hallaji, Siavash Gholami, Seyed Younes Hosseini, Zahra Musavi, Shahin Merat, Mohamad Ali Dehyadegari, Tayebeh Hashempour
Publikováno v:
Current Proteomics. 17:154-170
Background:: HCV Alternate Reading Frame Protein (ARFP) is a frameshift product of HCV-core encoding. Here, we characterized specific anti-ARFP antibodies in Liver Transplant Candidate (LTC) and chronic HCV-infected patients. Methods:: The ARFP gene